Familial Mediterranean fever in Japan
Kiyoshi Migita1, Ritei Uehara, Yoshikazu Nakamura
1From the Clinical Research Center (KM, H Ishibashi), Nagasaki Medical Center, Omura, Nagasaki; Institute of Tropical Medicine (NEKKEN) (M Yasunami), Nagasaki University, Nagasaki; Department of Rheumatology (AK), Nagasaki University Hospital, Nagasaki; Department of Public Health (RU, YN), Jichi Medical University, Tochigi; Department of Medicine (Neurology and Rheumatology) (ATS, M Yazaki, AN), Department of Pathology (JM), Department of Infection and Host Defense (KY, KA), Shinshu University School of Medicine, Matsumoto; Department of Pediatrics (AY), School of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa; Clinical Research Center (HF), Sagamihara National Hospital, National Hospital Organization, Sagamihara, Kanagawa; Department of Rheumatology (H Ida), Kurume University School of Medicine, Kurume; Japan. *Study Group of Familial Mediterranean Fever for Research on Intractable Diseases, Health and Labour Science Research Grants, Ministry of Health, Labour and Welfare of Japan.
Abstract:
Familial Mediterranean fever (FMF) is a hereditary autoinflammatory disease that is prevalent in Mediterranean populations. While it is considered a rare disease in the rest of world, a significant number of FMF patients have been reported in East Asia, including Japan. Our aim was to determine the prevalence of FMF in Japan and elucidate the clinical and genetic features of Japanese patients. A primary nationwide survey of FMF was conducted between January and December 2009. Hospitals specializing in pediatrics and hospitals with pediatric, internal medicine, and rheumatology/allergy departments were asked to report all patients with FMF during the survey year. The estimated total number of Japanese FMF patients was 292 (95% confidence interval, 187-398 people). We evaluated the clinical and genetic profiles of Japanese patients from the data obtained in a secondary survey of 134 FMF patients. High-grade fever was observed in 95.5%, chest pain (pleuritis symptoms) in 36.9%, abdominal pain (peritonitis symptoms) in 62.7%, and arthritis in 31.3%. Of the patients profiled, 25.4% of patients experienced their first attack before 10 years of age, 37.3% in their teens, and 37.3% after age 20 years. Colchicine was effective in 91.8% of patients at a relatively low dose (mean dose, 0.89 ± 0.45 mg/d). AA amyloidosis was confirmed in 5 patients (3.7%). Of the 126 patients studied, 109 (86.5%) were positive for 1 or more genetic mutations and 17 (13.5%) had no mutation detected. Common Mediterranean fever gene (MEFV) mutations were E148Q/M694I (19.8%) and M694I/normal (12.7%). The differences in the prevalence of peritonitis, pleuritis, and a family history of FMF were statistically significant between FMF patients with MEFV exon 10 mutations compared with those without exon 10 mutations.In conclusion, a significant number of patients with FMF exist in Japan. Although Japanese patients with FMF are clinically or genetically different from Mediterranean patients, the delay in diagnosis is an issue that should be resolved.
More Related Videos
12:20Bacterial Artificial Chromosomes: A Functional Genomics Tool for the Study of Positive-strand RNA Viruses
Published on: December 29, 2015
09:37Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique
Published on: September 23, 2022
Related Concept Videos
Patterns of Fever
Methods of reducing fever
Pharmacological Methods of Reducing Fever:
Types of Fever
Here are the different types of fever:
Arboviral Encephalitis
Infectious Diseases and Their Occurrence
Myocarditis I: Introduction
